Press Releases AC Immune SA

Equities

ACIU

CH0329023102

Real-time Estimate Cboe BZX Other stock markets 12:56:26 2024-04-29 pm EDT			5-day change	1st Jan Change
2.445 ^USD	+4.04%		+0.83%	-51.20%

Mar. 15	AC Immune Files $350 Million Mixed Shelf	MT
Mar. 14	AC Immune SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update	Mar. 14	AQ
AC Immune Announces Upcoming Presentations at AD/PD™ 2024	Feb. 22	AQ
AC Immune to Regain Global Rights to Crenezumab and Semorinemab	Jan. 22	AQ
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases	Jan. 03	AQ
AC Immune : Underwriting Agreement - Form 6-K	Dec. 19	PU
AC Immune's Targeted Anti-PTau Active Immunotherapy for Alzheimer's disease Advances into Phase 2b Trial	Dec. 18	AQ
AC Immune Announces Pricing of Underwritten Offering of Common Shares	Dec. 18	AQ
AC Immune Announces Pricing of Underwritten Offering of Common Shares	Dec. 15	AQ
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial	Dec. 15	AQ
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO	Dec. 04	AQ
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO	Dec. 01	AQ
Women in Stem with Andrea Pfeifer	Nov. 30	AQ
AC Immune to Present at the Jefferies 2023 London Healthcare Conference	Nov. 07	AQ
AC Immune: Q3 Earnings Snapshot	Nov. 03	AQ
AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update	Nov. 03	AQ
AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023	Nov. 02	AQ
AC Immune Clinical Data Published In Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic	23-10-30	AQ
AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic	23-10-27	AQ
AC Immune Announces Upcoming Presentations at the 16th CTAD Conference	23-10-17	AQ
AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023	23-10-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AC Immune SA

Equities

ACIU

CH0329023102

Press Releases

Filters